Your browser doesn't support javascript.
loading
Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial.
Fernández-García, José Carlos; Barrios-Rodríguez, Rocío; Asenjo-Plaza, Maite; Ramos-Molina, Bruno; Molina-Vega, María; Guzmán-Guzmán, Antonio; Moreno-León, Luis; Yubero-Serrano, Elena M; Rius-Díaz, Francisca; Valdés, Sergio; Martínez-González, Miguel Ángel; Jiménez-Moleón, José Juan; Tinahones, Francisco J.
Afiliação
  • Fernández-García JC; Department of Endocrinology and Nutrition, Hospital Regional Universitario de Malaga (IBIMA), Faculty of Medicine, University of Malaga, Malaga, Spain; Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain; Department
  • Barrios-Rodríguez R; Universidad de Granada, Departamento de Medicina Preventiva y Salud Pública, Granada, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain.
  • Asenjo-Plaza M; Cruz de Humilladero Primary Care Center, Malaga, Spain.
  • Ramos-Molina B; Obesity and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB-Arrixaca), Murcia, Spain.
  • Molina-Vega M; Department of Endocrinology and Nutrition, Hospital Virgen de la Victoria (IBIMA), Faculty of Medicine, University of Malaga, Malaga, Spain.
  • Guzmán-Guzmán A; Clinical Trials Unit, Pharmacy Department, Virgen de la Victoria University Hospital, Malaga, Spain.
  • Moreno-León L; Department of Endocrinology and Nutrition, Hospital Virgen de la Victoria (IBIMA), Faculty of Medicine, University of Malaga, Malaga, Spain.
  • Yubero-Serrano EM; Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.
  • Rius-Díaz F; Department of Epidemiology and Public Health, University of Malaga, Malaga, Spain.
  • Valdés S; Department of Endocrinology and Nutrition, Hospital Regional Universitario de Malaga (IBIMA), Faculty of Medicine, University of Malaga, Malaga, Spain; Spanish Biomedical Research Network in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain.
  • Martínez-González MÁ; Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain; Department of Preventive Medicine and Public Health, IDISNA, University of Navarre, Pamplona, Spain; Department of Nutrition, Harvard T.H. Chan School of Public He
  • Jiménez-Moleón JJ; Universidad de Granada, Departamento de Medicina Preventiva y Salud Pública, Granada, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain.
  • Tinahones FJ; Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain; Department of Endocrinology and Nutrition, Hospital Virgen de la Victoria (IBIMA), Faculty of Medicine, University of Malaga, Malaga, Spain.
Metabolism ; 136: 155290, 2022 11.
Article em En | MEDLINE | ID: mdl-35985506

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Resistência à Insulina / Disfunção Erétil / Metformina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Metabolism Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Resistência à Insulina / Disfunção Erétil / Metformina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Metabolism Ano de publicação: 2022 Tipo de documento: Article